Nurix TherapeuticsNRIX
13F holders, Q3 2024 (September 30)172holders −2
27new positions
30sold out
8famous investors
$22.47avg. 13F price*
At the end of Q3 2024, 172 institutions reported holding Nurix Therapeutics Inc. (NRIX) in their 13F filings, down 2 from Q2 2024. 27 opened new positions and 30 sold out. The largest holders were BlackRock, Inc. ($161.4M), Redmile Group, LLC ($96.2M) and Vanguard Group Inc. ($90.1M). 8 famous investors held it, including Cathie Wood (0.5% of ARK Investment Management's portfolio), Ken Griffin (0.0% of Citadel Advisors's portfolio) and Stanley Druckenmiller (0.0% of Duquesne Family Office's portfolio).
- Company
- Nurix Therapeutics Inc.
- CUSIP
- 67080M103
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q2 2024 → Q3 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 27 | $105.3M |
| Exits | 30 | $31.1M |
All 13F filers, Q2 2024 → Q3 2024: 8,926,321 shares bought and 6,418,673 shares sold, net +2,507,648 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 172 holders
| BlackRock, Inc. | 0.00% | — | 7,181,535 | $161.4M |
| Redmile Group, LLC | 5.67% | Reduce -3.2% | 4,280,981 | $96.2M |
| Vanguard Group Inc. | 0.00% | Add +10.7% | 4,011,814 | $90.1M |
| Baker Bros. Advisors LP | 0.91% | No change | 3,882,125 | $87.2M |
| Deep Track Capital, LP | 2.77% | Reduce -3.1% | 3,868,104 | $86.9M |
| Wellington Management Group LLP | 0.01% | Add +8.8% | 3,482,105 | $78.2M |
| T. Rowe Price Associates Inc. | 0.01% | Add +8.3% | 3,068,961 | $69.0M |
| T. Rowe Price Investment Management, Inc. | 0.03% | Add +16.4% | 2,548,091 | $57.3M |
| State Street Corp. | 0.00% | Reduce -12.4% | 2,371,271 | $53.3M |
| ARK Investment Management | 0.46% | Reduce -4.6% | 2,216,365 | $49.8M |
| Morgan Stanley | 0.00% | Reduce -5.6% | 1,878,564 | $42.2M |
| Pictet Asset Management Holding SA | 0.04% | Add +52.4% | 1,788,530 | $40.2M |
| Commodore Capital LP | 2.32% | New | 1,650,000 | $37.1M |
| Citadel Advisors | 0.04% | Add +47.1% | 1,531,205 | $34.4M |
| Geode Capital Management, LLC | 0.00% | Add +9.6% | 1,448,040 | $32.5M |
| Driehaus Capital Management LLC | 0.25% | Add +0.2% | 1,285,632 | $28.9M |
| Soleus Capital Management, L.P. | 1.99% | Reduce -48.2% | 1,065,834 | $23.9M |
| Candriam S.C.A. | 0.14% | Reduce -8.8% | 1,061,959 | $23.9M |
| Affinity Asset Advisors, LLC | 3.22% | Reduce -5.7% | 860,399 | $19.3M |
| Deutsche Bank AG | 0.01% | Reduce -18.5% | 854,682 | $19.2M |
| Wasatch Advisors LP | 0.08% | Reduce -17.4% | 708,377 | $15.9M |
| Nuveen Asset Management, LLC | 0.00% | Reduce -31.4% | 673,554 | $15.1M |
| FMR LLC | 0.00% | Add +675.9% | 586,902 | $13.2M |
| Samlyn Capital, LLC | 0.21% | Reduce -2.6% | 568,264 | $12.8M |
| Northern Trust Corp. | 0.00% | Add +29.4% | 566,855 | $12.7M |
| Boxer Capital, LLC | 0.62% | New | 563,067 | $12.7M |
| Sumitomo Mitsui Trust Group, Inc. | 0.01% | New | 553,251 | $12.4M |
| Amova Asset Management Americas, Inc. | 0.14% | New | 552,602 | $12.4M |
| Goldman Sachs Group Inc. | 0.00% | Add +10.5% | 513,221 | $11.5M |
| Charles Schwab Investment Management Inc. | 0.00% | Reduce -17.9% | 511,720 | $11.5M |
| Dimensional Fund Advisors LP | 0.00% | Reduce -16.8% | 501,569 | $11.3M |
| Parkman Healthcare Partners LLC | 1.26% | Reduce -7.5% | 438,971 | $9.9M |
| Vestal Point Capital, LP | 0.75% | Reduce -15.0% | 425,000 | $9.5M |
| Opaleye Management Inc. | 1.60% | Add +0.3% | 420,000 | $9.4M |
| Invesco Ltd. | 0.00% | Add +13.2% | 413,340 | $9.3M |
| Schonfeld Strategic Advisors LLC | 0.06% | Reduce -17.7% | 355,602 | $8.0M |
| Lord, Abbett & Co. LLC | 0.03% | New | 350,640 | $7.9M |
| Woodline Partners LP | 0.06% | Add +11.6% | 336,879 | $7.6M |
| Patient Square Capital LP | 2.72% | New | 325,789 | $7.3M |
| Norges Bank | 0.00% | Reduce -37.2% | 318,800 | $7.2M |
| ArrowMark Colorado Holdings LLC | 0.09% | No change | 314,762 | $7.1M |
| Bessemer Group Inc. | 0.01% | Add +0.0% | 306,053 | $6.9M |
| Rhenman & Partners Asset Management AB | 0.55% | Add +72.0% | 300,000 | $6.7M |
| Primecap Management Co. | 0.00% | No change | 290,000 | $6.5M |
| Ikarian Capital, LLC | 1.81% | Reduce -41.0% | 260,000 | $5.8M |
| Renaissance Technologies | 0.01% | Reduce -23.9% | 246,400 | $5.5M |
| Voloridge Investment Management, LLC | 0.02% | Reduce -28.0% | 241,048 | $5.4M |
| WestHill Financial Advisors, Inc. | 1.20% | Reduce -15.9% | 238,333 | $5.4M |
| Millennium Management | 0.00% | Reduce -63.0% | 221,718 | $5.0M |
| Qube Research & Technologies Ltd | 0.01% | Add +125.0% | 214,728 | $4.8M |
| Stempoint Capital LP | 1.37% | Reduce -0.1% | 203,015 | $4.6M |
| Integral Health Asset Management, LLC | 0.53% | Add +33.3% | 200,000 | $4.5M |
| Ensign Peak Advisors, Inc | 0.01% | Add +405.0% | 180,000 | $4.0M |
| Bank of New York Mellon Corp | 0.00% | Reduce -16.2% | 175,266 | $3.9M |
| Informed Momentum Co LLC | 0.59% | Add +0.4% | 174,760 | $3.9M |
| Fred Alger Management, LLC | 0.02% | Add +336.1% | 166,014 | $3.7M |
| Trexquant Investment LP | 0.05% | Reduce -33.3% | 159,261 | $3.6M |
| Jane Street Group, LLC | 0.01% | Reduce -21.2% | 157,619 | $3.5M |
| Susquehanna Portfolio Strategies, LLC | 0.24% | Reduce -1.2% | 154,044 | $3.5M |
| Allspring Global Investments Holdings, LLC | 0.00% | New | 140,273 | $3.2M |
| Bank of America Corp. | 0.00% | Reduce -37.6% | 138,124 | $3.1M |
| Franklin Resources Inc. | 0.00% | Add +52.4% | 123,101 | $3.1M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 0.00% | Reduce -0.1% | 128,524 | $2.9M |
| Barclays PLC | 0.00% | Add +77.9% | 128,344 | $2.9M |
| Hudson Bay Capital Management LP | 0.02% | New | 125,000 | $2.8M |
| Kennedy Capital Management LLC | 0.06% | Add +90.2% | 113,838 | $2.6M |
| Swiss National Bank | 0.00% | Add +7.8% | 106,900 | $2.4M |
| Acadian Asset Management LLC | 0.01% | Reduce -7.3% | 106,861 | $2.4M |
| Cinctive Capital Management LP | 0.14% | New | 105,228 | $2.4M |
| UBS Group AG | 0.00% | Reduce -13.2% | 102,866 | $2.3M |
| Jasper Ridge Partners, L.P. | 0.06% | No change | 95,711 | $2.2M |
| Rafferty Asset Management, LLC | 0.01% | Reduce -31.8% | 93,593 | $2.1M |
| Rhumbline Advisers | 0.00% | Add +2.4% | 90,918 | $2.0M |
| Vienna Powszechne Towarzystwo Emerytalne S.A. Vienna Insurance Group | 0.81% | No change | 85,000 | $1.9M |
| D. E. Shaw & Co. | 0.00% | New | 72,840 | $1.6M |
| Massachusetts Financial Services Co. | 0.00% | Reduce -29.3% | 69,415 | $1.6M |
| Boothbay Fund Management, LLC | 0.05% | Reduce -41.0% | 69,134 | $1.6M |
| JPMorgan Chase & Co. | 0.00% | Add +85.2% | 68,148 | $1.5M |
| Squarepoint Ops LLC | 0.01% | Add +133.7% | 67,280 | $1.5M |
| Twinbeech Capital LP | 0.03% | New | 65,459 | $1.5M |
| Alliancebernstein L.P. | 0.00% | No change | 63,320 | $1.4M |
| Legal & General Group Plc | 0.00% | Add +17.7% | 59,899 | $1.3M |
| Two Sigma Advisers, LP | 0.00% | Reduce -34.0% | 59,100 | $1.3M |
| ClariVest Asset Management LLC | 0.13% | No change | 63,149 | $1.3M |
| California State Teachers Retirement System | 0.00% | Add +5.0% | 52,454 | $1.2M |
| Two Sigma Investments, LP | 0.00% | Reduce -16.7% | 50,709 | $1.1M |
| Citigroup Inc. | 0.00% | Add +80.8% | 49,593 | $1.1M |
| AQR Capital Management | 0.00% | Add +120.3% | 46,920 | $1.1M |
| Duquesne Family Office | 0.03% | No change | 44,200 | $993K |
| Royal Bank of Canada | 0.00% | Add +646.9% | 43,248 | $973K |
| Federated Hermes, Inc. | 0.00% | New | 42,204 | $948K |
| TD Asset Management Inc | 0.00% | Add +42.2% | 40,434 | $932K |
| Wells Fargo & Company | 0.00% | Add +61.0% | 40,803 | $917K |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 0.00% | Add +30.6% | 38,619 | $870K |
| State of Wisconsin Investment Board | 0.00% | Add +5.6% | 37,096 | $834K |
| MetLife Investment Management, LLC | 0.00% | Add +0.5% | 35,239 | $792K |
| ExodusPoint Capital Management, LP | 0.01% | Reduce -89.2% | 34,613 | $778K |
| Corebridge Financial, Inc. | 0.00% | Add +4.8% | 34,137 | $767K |
| Mariner, LLC | 0.00% | Add +0.7% | 31,795 | $714K |
| Manufacturers Life Insurance Company, The | 0.00% | Add +32.4% | 30,383 | $683K |
"% of holder's portfolio" is NRIX's weight in each manager's 13F, not the share of Nurix Therapeutics Inc. the manager owns.